Human glioma demonstrates cell line specific results with ATP-based chemiluminescent cellular proliferation assays

[1]  M. Campone,et al.  Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. , 2009, Current molecular pharmacology.

[2]  Barbara L Parsons,et al.  Many different tumor types have polyclonal tumor origin: evidence and implications. , 2008, Mutation research.

[3]  R. Schifman,et al.  Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth , 1987, In Vitro Cellular & Developmental Biology.

[4]  K. Soliman,et al.  Anaerobic Glycolysis Protection against 1-Methy-4-Phenylpyridinium (MPP+) Toxicity in C6 Glioma Cells , 2007, Neurochemical Research.

[5]  G. Gobbel,et al.  Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis , 2005, Laboratory Investigation.

[6]  I. Cree,et al.  Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements. , 2005, Methods in molecular medicine.

[7]  I. Cree,et al.  Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma , 2003, BMC Cancer.

[8]  F. Nicolantonio,et al.  Heterogeneity of chemosensitivity of esophageal and gastric carcinoma , 2003, Anti-cancer drugs.

[9]  I. Cree,et al.  Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA) , 2003, Anti-cancer drugs.

[10]  I. Cree,et al.  Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. , 1995, Cancer research.

[11]  P. Andreotti,et al.  In vitro activity of titanocenedichloride versus cisplatin in four ovarian carcinoma cell lines evaluated by a microtiter plate ATP bioluminescence assay , 1995, Anti-cancer drugs.

[12]  I. Cree,et al.  Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay. , 1995, Anti-cancer drugs.

[13]  R. Kozłowski,et al.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. , 1993, Journal of immunological methods.

[14]  H. Ichihashi,et al.  [A new chemosensitivity test for cancer cells by measuring intracellular ATP content]. , 1988, Nihon Geka Gakkai zasshi.

[15]  Y. Maehara,et al.  Comparison of the chemosensitivity of human neoplastic tissues between succinate dehydrogenase inhibition test and ATP assay. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[16]  Y. Maehara,et al.  The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viability. , 1987, European journal of cancer & clinical oncology.

[17]  Y. Maehara,et al.  [Comparison between the succinate dehydrogenase inhibition test and ATP assay for in vitro chemosensitivity testing]. , 1987, Gan to kagaku ryoho. Cancer & chemotherapy.

[18]  Y. Maehara,et al.  Comparison between succinate dehydrogenase inhibition test and subrenal capsule assay for chemosensitivity testing. , 1987, Oncology.

[19]  R B Schifman,et al.  ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects. , 1986, Journal of the National Cancer Institute.

[20]  J. Perkins,et al.  The involvement of cellular ATP in receptor-mediated internalization of epidermal growth factor and hormone-induced internalization of beta-adrenergic receptors. , 1986, The Journal of biological chemistry.

[21]  K. Nagai,et al.  Quantitative and Continuous Analysis of ATP Release from Blood Platelets with Firefly Luciferase Luminescence , 1985, Thrombosis and Haemostasis.

[22]  L. Kangas,et al.  Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. , 1984, Medical biology.